New Dendreon CEO recruits ImClone vets for executive team; LSU team discovers new stroke molecule;

Biotech News

@FierceBiotech: Dainippon bags Boston Biomedical and cancer stem cell tech in $2.6B buyout, with 200M upfront and lots of biobucks. News | Follow @FierceBiotech

 @JohnCFierce: Cowen's Simos Simeonidis calls $VVUS raise a "decent insurance policy" against an unexpected setback on approval. Expects approval. | Follow @JohnCFierce

@RyanMFierce: Kudos to Roger Tung of Concert, who told me JPM 2012 that he'd land a new deal soon, and he did it. Not all biotech CEOs deliver like that. | Follow @RyanMFierce

@FierceMedDev: NovaSom moves test for obstructive sleep apnea from the lab to the home. Release | Follow @FierceMedDev

@MarkHFierce: Could proper brain sugar levels manage or prevent Alzheimer's? I don't think they mean the kind of sugar I like. More | Follow @MarkHFierce

> The new CEO at Dendreon is quickly assembling his turnaround team. John Johnson has hired Joe DePinto as the new EVP of global commercial operations and Christine Mikail is joining Dendreon as executive vice president, corporate development. Both of the new recruits are ImClone vets, like Johnson. Robert S. Poulton, meanwhile, was promoted to executive vice president, technical operations. Release

> Horizon Pharma has raised $50.8 million through a stock sale. The cash will fund Horizon's operations into mid-2013. Release

> Catalent is beefing up its drug delivery tech services after completing the acquisition of the R.P. Scherer Eberbach business. Release

Pharma News

@FiercePharma: Pfizer pulls one Prevnar lot because it was filled with expired material. FDA says caught early, at wholesale level. News | Follow @FiercePharma

> Mylan aims first Lexapro copy at Forest Labs. News

> Analysts eye Big Pharma suitors for Vivus. Item

Medical Device News

> Koning gets CE Mark for breast CT system. Item

> Globus, CEO slapped with $1M fine for distributing unapproved device. More

> Was Stryker's MacMillan ousted? Story

Biomarkers News

> Gene-based biomarkers could cut invasive bladder biopsies. Article

> MRI technique may serve as chronic pain biomarker. Item

> The unified theory of biomarkers: Stromedix and Biogen Idec. More

Drug Delivery News

> Iranian researchers test gold nanoparticle cancer drug delivery. More

> Drug delivery nanorockets ricochet riotously. Story

> Biogen Idec secures FDA nod for Avonex delivery accessory. Article

> Forest Labs to launch inhaled lung infection drug in Germany. News

And Finally… LSU's Nicolas Bazan believes he has discovered that a synthetic molecule protected the brain in a model of experimental stroke. Release